2014 PCNA Pharmacology Pre-Conference
Join us for an exciting new pre-conference session designed especially for advanced practice nurses to help meet the new renewal of certification requirements. We have assembled a team of 3 NPs who are thought leaders in cardiovascular nursing, along with a PharmD colleague to present 4 important topics in a clinically relevant and engaging format. This course will incorporate pre-course self-paced review/self-assessment and post-course assessment to provide a total of 7 contact hours in pharmacology!
Seminar Information
Seminar Date:
April 09, 2014
Pre-Course Self Evaluation
Welcome
Speaker Information
Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA   [ view bio ]
Hypertension
Learning Objectives:
  • Summarize the findings of two landmark clinical trials that help guide the management of hypertension in the patient with diabetes. (pre-course work) 
  • Define the concept of "compelling indications" in the choice of pharmacologic agent in the management of hypertension. (pre-course work) 
  • Summarize the indications for ACE, ARB, and β-blocker therapy in secondary prevention of cardiovascular disease. (in-place course) 
  • Identify the recommendations for monitoring renal function and potassium levels in patients with CKD who are prescribed ACEs or ARBs. (in-place course) 
  • Identify the role of advanced age in determining the starting dose(s) and titration of various antihypertensive agents (in-place course) 

Speaker Information
Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA   [ view bio ]
Unintended Cardiovascular Effects of Mood, Sleep and Pain Medications
Learning Objectives: 
  • Summarize the evidence regarding the safety of selective serotonin reuptake inhibitor (SSRI) antidepressants in patients with coronary heart disease 
  • Outline the role of cardiovascular disease (CVD) history and CVD risk assessment in safe prescribing of pharmacologic agents for mild to moderate pain relief 
  • List the factors that may increase the risk for cardiac side effects (including cardiac arrhythmias) associated with the administration of nonbenzodiazepine hypnotics 

Speaker Information
Kevin B. Sneed, PharmD   [ view bio ]
Antiplatelet Therapy
 Learning Objectives: 
  • Identify the source of evidence-based guidelines for antiplatelet therapy in the post PCI patient (pre-course work) 
  • Cite recommendations for low-dose aspirin as primary prevention of heart attack and stroke (pre-course work) 
  • Contrast the recommendations for antiplatelet therapy for patients post drug-eluting stent (DES) versus bare metal stent (BMS) (in-place course) 
  • Define the concept of platelet reactivity 
  • Quantify the impact of nonadherence to antiplatelet therapy on the occurrence of in-stent thrombosis 

Speaker Information
Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN   [ view bio ]
Anticoagulants
Learning Objective: 
  • Identify the factor(s) in the coagulation cascade on which warfarin, dabigatran, rivaroxaban and apixaban exert their respective anticoagulant effects (pre-course work) 
  • Identify 2 sources for evidence-based guidelines for antithrombotic therapy in the reduction of cardioembolic risk in the patient with non-valvular atrial fibrillation (pre-course work) 
  • List the major finding from each of the landmark clinical trials of new anticoagulant agents (RE-LY, ROCKET-AF, ARISTOTLE) (pre-course work) 
  • Define the impact of renal function and patient age on the choice of anticoagulant agent (in-place course) 
  • Distinguish which of the novel anticoagulants are indicated for treatment of VTE and DVT prophylaxis in the patient undergoing orthopedic surgery (in-place course) 

Speaker Information
Janet Long, MSN, ACNP, CLS, FAHA, FPCNA   [ view bio ]
Case Studies with All Faculty Panel
Learning Objective: 
  • Identify an evidence-based treatment plan for a patient with multiple comorbidities 

Speaker Information
Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN   [ view bio ]
Janet Long, MSN, ACNP, CLS, FAHA, FPCNA   [ view bio ]
Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA   [ view bio ]
Kevin B. Sneed, PharmD   [ view bio ]
Individual topic purchase: Selected

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.


ACCREDITOR:

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. 

 

Preventive Cardiovascular Nurses Association
Pharmacology Hours: 7.00
Contact Hour Total: 7.00
Products
2014 PCNA Pharmacology Pre-Conference
PCNA Member Price:$50.00
Non-Member Price:$50.00